Sparstolonin B inhibits lipopolysaccharide-induced inflammation in 3T3-L1 adipocytes
Sparstolonin B inhibits lipopolysaccharide-induced inflammation in 3T3-L1 adipocytes
复制标题
Sparstolonin B 抑制 3T3-L1 脂肪细胞中脂多糖诱导的炎症。
DOI:
10.1016/j.ejphar.2015.10.050
复制
发表时间:
2015-12-15
影响因子:
5
通讯作者:
Sun, Jia
中科院分区:
文献类型:
--
作者:
Wang, Ming;Xiu, Liangchang;Sun, Jia
Sparstolonin B (SsnB), an isocoumarin compound isolated from the tubers of both Sparganium stoloniferum and Scirpus yagara, has been reported to have anti-inflammatory effects. However, whether SsnB has anti-inflammatory effects on LPS-stimulated 3T3-L1 adipocytes remains unclear. In this study, we investigated the effects of SsnB on adipocyte inflammation in 3T3-L1 adipocytes and anti-obesity properties in high fat diet (HFD)-induced obese rats. 3T3-L1 adipocytes were pretreated with SsnB 1 h before LPS treatment. The expression of MCP-1, IL-6, TNIF-alpha, and IL-10 were measured by qRT-PCR and ELISA. The expression of PPAR-gamma, TLR4 and NF-kappa B were detected by western blotting. SsnB was administered to HFD-induced obese rats to confirm its effects in vivo. Our results showed that SsnB dosedependently inhibited LPS-induced MCP-1, IL-6, and TNIF-alpha production. SsnB was found to inhibit LPSinduced TLR4 expression and NF-kappa B activition. Furthermore, SsnB was found to activate PPAR-gamma and the inhibitory effects of SsnB on MCP-1, IL-6, and TNIF-alpha production can be reversed by PPAR-gamma antagonist GW9662. In vivo, SsnB was found to reduce the body weight of rats fed with HFD. SsnB also inhibited the levels of serum triglyceride (TG) and cholesterol (TC) induced by HFD. In conclusion, the results suggested that SsnB could reduce HFD-induced obesity in rats and inhibited LPS-induced cytokines production in 3T3-L1 adipocytes by activating PPAR-gamma. (C) 2015 Elsevier B.V. All rights reserved.